Overview: Apidra SoloStar is a state-of-the-art insulin glulisine injection designed to manage blood sugar levels effectively in patients with diabetes mellitus. Manufactured by Sanofi, a trusted name in pharmaceuticals, each package contains 5 pens, each filled with 3 mL of insulin glulisine solution. This product is specifically engineered to provide rapid-acting insulin to help control postprandial glucose spikes.
Active Substance: The active substance in Apidra SoloStar is insulin glulisine. Insulin glulisine is a rapid-acting insulin analogue that works faster than regular human insulin by mimicking the natural insulin response of the body. This rapid action ensures quick glucose uptake into cells, thereby reducing hyperglycemia swiftly after meals.
Formulation: Each Apidra SoloStar pen contains a sterile, aqueous solution of insulin glulisine. The solution is clear and colorless, designed for subcutaneous injection. The pen device is easy to use, offering precise dosing and user-friendly handling for patients requiring regular insulin therapy.
Package Contents:
- Quantity: 5 pens
- Volume per Pen: 3 mL
- Total Volume: 15 mL (5 pens × 3 mL each)
Manufacturer: Apidra SoloStar is manufactured by Sanofi, a global pharmaceutical company renowned for its commitment to quality and innovation in diabetes care.
Indications: Apidra SoloStar is indicated for the treatment of diabetes mellitus in adults, adolescents, and children aged 2 years and older. It is used to improve glycemic control by lowering blood glucose levels, particularly after meals.
Features and Benefits:
- Rapid Onset: Starts working quickly after injection, typically within 10-20 minutes.
- Short Duration: Effectiveness peaks within 1-2 hours and clears from the body faster than regular insulin.
- Flexible Dosing: Can be administered shortly before meals or immediately after, depending on the individual’s blood glucose level and dietary habits.
- Convenient Pen Design: Each pen is prefilled and ready for use, simplifying daily insulin administration.
- Accurate Dosage: Provides precise and consistent insulin dosing, enhancing treatment reliability.
Usage Instructions: Apidra SoloStar pens are designed for subcutaneous injection into the thigh, abdomen, or upper arm. Patients should follow healthcare provider instructions regarding dosage and injection technique. The pen device features dose increments that allow for tailored insulin delivery based on individual needs.
Storage and Handling:
- Store Apidra SoloStar pens in a refrigerator (2°C to 8°C) before opening.
- Pens in use or carried as spares can be stored at room temperature (below 30°C) for up to 28 days.
- Protect from light and heat. Do not freeze.
Precautions:
- Patients should monitor blood glucose levels regularly as directed by their healthcare provider.
- Hypoglycemia (low blood sugar) and hyperglycemia (high blood sugar) may occur. Patients should be educated on recognizing and managing these conditions.
- Inform healthcare providers about all medications being taken, including over-the-counter drugs and supplements.
Conclusion: Apidra SoloStar offers a reliable solution for managing diabetes mellitus with its rapid-acting insulin glulisine formulation. Designed for ease of use and precise dosing, this product exemplifies Sanofi’s commitment to advancing diabetes care through innovative pharmaceuticals.
Disclaimer: Always consult with a healthcare provider for personalized medical advice and treatment recommendations tailored to individual needs and conditions.
Reviews
There are no reviews yet.